RIA Kits
Please use the dropdown below to find out about RIA Kits available in the United States:
CA 15-3® Radioimmunoassay
Biomarker for early detection of breast cancer recurrence: Supported by over 2,000 peer-reviewed publications, CA 15-3® is indicated for the quantitative determination of DF3 antibody-defined antigen, encoded by the MUC 1 gene, in serum and plasma of patients previously treated for stage II or stage III breast cancer.
Download our CA 15-3 product literature: